|
|
||||||||
From the Department of Microbiology, The Johns Hopkins University, Baltimore, Maryland
Abstract
Serum from rats actively immune to Plasmodium berghei can inhibit the development of parasitemia and reduce morbidity to a marked extent when administered to normal recipients at the time of challenge. Smaller doses of potent serum, equivalent to less than 0.05% of the recipient's plasma volume, can also reduce parasitemia to a statistically significant extent. The protective activity of hyperimmune serum, which can be measured by a simple passive transfer assay, is primarily associated with the 7 S immunoglobulins. It persists in the circulation for more than 6 months after infection and rapidly increases on restimulation with the infectious agent.
Footnotes
1 Support for this investigation was provided, in part, by the National Science Foundation, GB-1120; the American Cancer Society, Inc., Grant T-257; the National Institute of Allergy and Infectious Diseases, United States Public Health Service, Grant AI-03151; and the Office of The Surgeon General, Department of the Army, under the auspices of the Commission of Immunization of the Armed Forces Epidemiological Board, Contract DA-49-193-MD-2468.
Presented in part at the Annual Meeting of the American Association of Immunologists, Atlantic City (Fed. Proc., 27: 369, 1968).
2 Portion of a dissertation submitted in partial fulfillment of the requirements for the Ph.D. degree. Present address: Chief, Department of Parasitology, USA Medical Component, SEATO, APO, San Francisco, Calif., 96346.
3 Present address: Department of Medical Immunology, The Public Health Research Institute of the City of New York, Inc., New York, N. Y. 10016, to which reprint requests should be addressed.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |